Page last updated: 2024-09-03

kadsurenone and angiotensin ii

kadsurenone has been researched along with angiotensin ii in 1 studies

Compound Research Comparison

Studies
(kadsurenone)
Trials
(kadsurenone)
Recent Studies (post-2010)
(kadsurenone)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
510338,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomykadsurenone (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Felsen, D; Freund, RM; Vaughan, ED; Weisman, SM1

Other Studies

1 other study(ies) available for kadsurenone and angiotensin ii

ArticleYear
Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction.
    Biochemical pharmacology, 1988, Aug-01, Volume: 37, Issue:15

    Topics: Angiotensin II; Animals; Benzofurans; Dinoprostone; Kidney; Lignans; Male; Peptides; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Prostaglandins E; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Triazolam; Ureteral Obstruction

1988